MD2324F1 - Metabolism regulating medicament - Google Patents
Metabolism regulating medicamentInfo
- Publication number
- MD2324F1 MD2324F1 MD20030188A MD20030188A MD2324F1 MD 2324 F1 MD2324 F1 MD 2324F1 MD 20030188 A MD20030188 A MD 20030188A MD 20030188 A MD20030188 A MD 20030188A MD 2324 F1 MD2324 F1 MD 2324F1
- Authority
- MD
- Moldova
- Prior art keywords
- metabolism regulating
- regulating medicament
- medicament
- encephalon
- ergocalciferol
- Prior art date
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention refers to medicine, namely to pharmacology and may be used for normalization of metabolic processes, compensation of the absolute or relative deficit of vitamins and mineral substances, in case of encephalon trauma, as well as for treatment of children up to 3 years, suffering from neurologic diseases and rickets. The medicament contains the following ingredients, in the ratio: calcium glycerophosphate 1,5...2,0 g; potassium orotate 1,0...2,0 g; lipoic acid 1,0...2,0 g; prednisolone 0,01...0,02 g; retinol 10000...20000 IU; ergocalciferol 5000...10000 IU; tocopherol acetate 300...6000 IU; folic acid 0,01...0,02 g and pasteurized nut oil 90...100 ml.Claims: 1
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20030188A MD2324G2 (en) | 2003-07-25 | 2003-07-25 | Metabolism regulating medicament |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20030188A MD2324G2 (en) | 2003-07-25 | 2003-07-25 | Metabolism regulating medicament |
Publications (2)
Publication Number | Publication Date |
---|---|
MD2324F1 true MD2324F1 (en) | 2003-12-31 |
MD2324G2 MD2324G2 (en) | 2004-07-31 |
Family
ID=32026194
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MDA20030188A MD2324G2 (en) | 2003-07-25 | 2003-07-25 | Metabolism regulating medicament |
Country Status (1)
Country | Link |
---|---|
MD (1) | MD2324G2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2591811C1 (en) * | 2015-06-25 | 2016-07-20 | Государственное бюджетное образовательное учреждение дополнительного профессионального образования "Новокузнецкий государственный институт усовершенствования врачей" Министерства здравоохранения Российской Федерации | Method of treating metabolic syndrome in emotiogenic type of eating behaviour |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD2903G2 (en) * | 2005-04-12 | 2006-06-30 | Ион ИЛИЧУК | Medicinal remedy for treatment of central and peripheral nervous system to children |
MD2904G2 (en) * | 2005-04-12 | 2006-06-30 | Каролина ВАРВАРЮК | Use of Gerovital H3 preparation for treatment of central nervous system affections to children |
MD3425G2 (en) * | 2007-05-17 | 2008-06-30 | ИЛИЧУК Ион | Method of prophylaxis and treatment of nervous system pathologies to children |
MD501Z (en) * | 2011-06-30 | 2012-11-30 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Method for prophylaxis of postradiation complications in oncologic diseases |
-
2003
- 2003-07-25 MD MDA20030188A patent/MD2324G2/en not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2591811C1 (en) * | 2015-06-25 | 2016-07-20 | Государственное бюджетное образовательное учреждение дополнительного профессионального образования "Новокузнецкий государственный институт усовершенствования врачей" Министерства здравоохранения Российской Федерации | Method of treating metabolic syndrome in emotiogenic type of eating behaviour |
Also Published As
Publication number | Publication date |
---|---|
MD2324G2 (en) | 2004-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5597585A (en) | Vitamin/mineral composition | |
NO20063328L (en) | Use of a fatty acid composition comprising at least one of EPA and DHA or combinations thereof | |
AU2466500A (en) | Pharmaceutical compositions for alleviating discomfort | |
AU2008313418A8 (en) | Composition for regulating lipid metabolism | |
MXPA05009933A (en) | Compositions comprising fatty acids and amino acids. | |
BR0214838A (en) | Composition for promoting bone growth and maintaining bone health | |
WO2006099233B1 (en) | Compositions and methods for the treatment of osteoporosis and inflammatory joint disease | |
CY1112547T1 (en) | Means Containing Folic Acid, Vitamin B6 And Vitamin B12, And Their Use | |
KR20180021674A (en) | Phyto complexes exhibiting multiple synergistic antioxidant activities useful in food, dietary supplements, cosmetic preparations and pharmaceutical preparations | |
UA88165C2 (en) | Use of trisubstituted benzopyranones | |
Jackson et al. | Metabolism of selenite to selenosugar and trimethylselenonium in vivo: tissue dependency and requirement for S-adenosylmethionine-dependent methylation | |
Strohle et al. | Micronutrients at the Interface between Inflammation and Infection Ascorbic Acid and Calciferol. Part 2: Calciferol and the Significance of Nutrient Supplements | |
MD2324F1 (en) | Metabolism regulating medicament | |
UA91028C2 (en) | Use of lavender oil for the prophylaxis and treatment of neuro asthenia, somatization disorders and other diseases associated with stress | |
US20180289740A1 (en) | Nutritional composition for providing relief from wine induced headaches | |
DE50310932D1 (en) | SPOROPOLLENINE CONTAINING SOLUBLE COMPOSITION AND USE | |
MD2903G2 (en) | Medicinal remedy for treatment of central and peripheral nervous system to children | |
Kree | Mis on D-vitamiin? | |
EP2514429B1 (en) | Antioxidant | |
WO2011041920A3 (en) | Nutraceutical composition that comprises extract of shilajit, folic acid, vitamin b12 and vitamin b6 and the use thereof for preventing and/or treating neurodegenerative diseases and/or the cognitive deterioration associated with cerebral ageing | |
Van Schoor | The value of supplements | |
Van Schoor | Vitamin and mineral supplements | |
MX2022012599A (en) | 25-hydroxyvitamin d2 and/or d3 for use in obesity. | |
Glibowski et al. | Health consequences of vitamin D deficiency in the human body | |
Hozyasz et al. | Effects of the introduction of oriental species to polish diet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Patent for invention definitely lapsed due to non-payment of fees |